| Brenda Faye Jones, MD | |
|
330 N Sandhill Blvd Ste A, Mesquite, NV 89027-4779 | |
| (702) 346-2950 | |
| (702) 346-3795 |
| Full Name | Brenda Faye Jones |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 44 Years |
| Location | 330 N Sandhill Blvd Ste A, Mesquite, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588663645 | NPI | - | NPPES |
| P01296262 | Other | OH | RAILROAD MEDICARE - MHCPI |
| 1588663645 | Medicaid | NV | |
| 0672106 | Medicaid | OH | |
| 1588663645 | Medicaid | UT | |
| 0095420000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 55641 (Ohio) | Secondary |
| 207W00000X | Ophthalmology | 17844 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sharon Richens Md Eye Physician And Surgeon Pc | 4385605799 | 9 |
| Sharon Richens Md Eye Physician And Surgeon Pc | 4385605799 | 9 |
News Archive
Researchers from RMIT University have developed a new artificial enzyme that uses light to kill bacteria.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
Some Capitol Hill lawmakers are increasingly pushing to find a way to avert a fiscal crisis. Also in the news from Congress, Republicans continue their investigation of the White House's negotiations with health care interest groups during the health law debate in 2009.
The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive.
› Verified 6 days ago
| Entity Name | Sharon Richens Md Eye Physician & Surgeon Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891892063 PECOS PAC ID: 4385605799 Enrollment ID: O20041019001453 |
News Archive
Researchers from RMIT University have developed a new artificial enzyme that uses light to kill bacteria.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
Some Capitol Hill lawmakers are increasingly pushing to find a way to avert a fiscal crisis. Also in the news from Congress, Republicans continue their investigation of the White House's negotiations with health care interest groups during the health law debate in 2009.
The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Faye Jones, MD 161 W 200 N Ste 200, St George, UT 84770-7386 Ph: (435) 986-2020 | Brenda Faye Jones, MD 330 N Sandhill Blvd Ste A, Mesquite, NV 89027-4779 Ph: (702) 346-2950 |
News Archive
Researchers from RMIT University have developed a new artificial enzyme that uses light to kill bacteria.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
Some Capitol Hill lawmakers are increasingly pushing to find a way to avert a fiscal crisis. Also in the news from Congress, Republicans continue their investigation of the White House's negotiations with health care interest groups during the health law debate in 2009.
The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive.
› Verified 6 days ago